Vaccine Clinical Development Expertise

Preventing and Treating Cancers and Infectious Diseases

Vaccine developers worldwide are faced with the challenge of quickly and safely advancing their vaccines through clinical development and approval to prevent millions of deaths every year. Infectious disease pandemics like Ebola, MERS and COVID-19 come to mind currently, requiring a rapid response to a regional or global outbreak. Equally important are vaccines to prevent or treat cancers, viral, and bacterial infections that impact the length or quality of human lives.

Understanding Vaccines

We understand that vaccine development has a unique set of challenges, so Veristat has assembled an extraordinary team of scientific-minded experts who have planned and executed over 140 vaccine clinical trials and supported 8 BLA marketing applications.

Whether a vaccine to prevent or treat cancer recurrance or progression, or rapidly responding to an infectious disease outbreak, like the ongoing COVID-19 pandemic, we solve the problems that arise in testing immunotherapy vaccines, live or inactivated viral vaccines or DNA vaccines.